Insider Transactions in Q1 2025 at Repare Therapeutics Inc. (RPTX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 12
2025
|
Lloyd Mitchell Segal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
21,179
-14.55%
|
$21,179
$1.14 P/Share
|
|
Mar 12
2025
|
Steve Forte EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,884
-11.16%
|
$6,884
$1.14 P/Share
|
|
Mar 12
2025
|
Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
5,611
-6.53%
|
$5,611
$1.14 P/Share
|
|
Mar 12
2025
|
Maria Koehler EVP, CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,596
-1.55%
|
$3,596
$1.14 P/Share
|
|
Mar 04
2025
|
Steve Forte EVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+18.5%
|
-
|
|
Mar 04
2025
|
Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+14.01%
|
-
|
|
Mar 04
2025
|
Lloyd Mitchell Segal PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+21.55%
|
-
|